Invasive treatment in peripheral artery disease

Curr Opin Pharmacol. 2018 Apr:39:113-120. doi: 10.1016/j.coph.2018.01.013.

Abstract

Invasive treatment in peripheral artery disease (PAD) has evolved as a viable alternative to surgical treatment. However, beyond the common pathophysiological substrate, as far as treatment is concerned, each site of atherosclerotic disease (subclavian and vertebral arteries; carotid arteries; intracranial arterial tree; renal arteries; lower extremity arteries) features unique characteristics. Treatment options include medical treatment, endovascular management and/or surgery. Sound clinical evaluation is required as individual patient assessment often limits intervention options, while available data regarding benefits of invasive and surgical management are questioned by advances in medical treatment. In the present article, we aim to summarize existing evidence and guidance on the role of invasive procedures in PAD.

Publication types

  • Review

MeSH terms

  • Carotid Artery Diseases / therapy*
  • Humans
  • Lower Extremity / blood supply
  • Peripheral Arterial Disease / therapy*
  • Renal Artery*
  • Subclavian Artery*
  • Vertebral Artery*